T86.31 Heart-lung transplant rejection

Name of the Condition

• Heart-lung transplant rejection

Summary

Heart-lung transplant rejection refers to an immune-mediated adverse event that occurs after a combined heart and lung transplant, where the body's immune system attacks the transplanted organs, potentially impairing their function. This condition requires prompt recognition and management to preserve graft viability and patient outcomes.

Causes

Rejection typically results from the recipient's immune system recognizing the transplanted organs as foreign, triggering an immune response. This can be acute (occurring within weeks to months) or chronic (developing over time). Immunosuppressive therapy non-adherence or inadequate dosing may also contribute to rejection episodes.

Risk Factors

• History of prior organ rejection or transplant complications
• Inadequate or fluctuating immunosuppressive therapy
• Mismatched donor-recipient human leukocyte antigen (HLA) compatibility
• Pre-existing infections or comorbidities (e.g., autoimmune diseases)
• Advanced age or poor overall health status

Symptoms

• Fever or chills
• Shortness of breath or worsening respiratory function
• Fatigue or malaise
• Chest pain or discomfort
• Swelling or tenderness at the transplant site
• Decreased organ function (e.g., reduced oxygenation, elevated pulmonary pressures)
• Unexplained weight loss

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests (e.g., blood work, immunological markers), imaging studies (e.g., chest X-ray, CT, or echocardiography), and sometimes biopsy of the transplanted organs to assess for rejection. Monitoring for signs of organ dysfunction and immune activity is critical.

Treatment Options

Treatment focuses on suppressing the immune response, often with increased or adjusted immunosuppressive medications (e.g., corticosteroids, antithymocyte globulin). Supportive care, such as oxygen therapy or mechanical ventilation, may be needed for respiratory compromise. In severe cases, retransplantation may be considered.

Prognosis and Follow-Up

Prognosis depends on the rejection type, severity, and timeliness of treatment. Acute rejection is often reversible with prompt intervention, while chronic rejection may lead to progressive organ dysfunction. Long-term follow-up with regular monitoring of organ function and immunosuppressive levels is essential to detect and manage recurrence.

Complications

• Chronic rejection leading to graft failure
• Infection due to immunosuppression
• Cardiovascular complications (e.g., heart failure)
• Respiratory failure
• Adverse effects from immunosuppressive therapy (e.g., nephrotoxicity, hypertension)

Lifestyle & Prevention

• Strict adherence to prescribed immunosuppressive regimens
• Avoidance of infections (e.g., vaccinations, hygiene practices)
• Regular follow-up appointments and monitoring
• Lifestyle modifications (e.g., smoking cessation, balanced diet)
• Prompt reporting of new or worsening symptoms

When to Seek Professional Help

Seek immediate medical attention for symptoms such as severe shortness of breath, chest pain, high fever, or signs of infection. Early intervention is critical to prevent irreversible organ damage.

Tips for Medical Coders

Document the type of rejection (acute, chronic, or antibody-mediated) and any associated complications. Ensure clinical notes specify the involvement of the heart, lung, or both to support accurate coding. Include details on treatment responses and follow-up findings to reflect the full clinical picture.